A group that represents pharmacies that have been producing off-brand versions of GLP-1 weight-loss drugs just filed another ...

A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for ...

People who have depended on off-brand versions of Wegovy and Ozempic will likely have to pay more now that a nationwide ...

If Australia followed England’s lead and listed drugs such as Wegovy on the PBS for weight loss, this could bring the cost ...

Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent study.

This will be a “pivotal year,” one expert says, for GLP-1 drugs, which are massively disrupting the benefits landscape.

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

Health plans are lobbying the Trump administration to scrap a proposal dating from the final days of the Biden administration ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Meanwhile, Danish health officials — where Ozempic manufacturer Novo Nordisk is based — are currently investigating potential links between semaglutide and vision loss. Though the researchers ...